You should contact your GP or diabetes care team urgently if you experience excessive thirst accompanied by increased urination (polyuria), unexplained weight loss, persistent fatigue, or blurred vision
The trial is expected to run until October 2027
Notifications of possible adverse events followed routine pharmacovigilance procedures and were not collected in the study
Our Grass Valley providers are experts in semaglutide weight loss solutions, and our dedicated team takes care of insurance and prior authorization so that you can concentrate solely on your health goals
5. Side Effects & Clinical Precautions 6. How to Administer Obesema Injection 7. Mechanism of Action: The Science Behind 0.25mg 8. Safety & Lifestyle Management 9. Management of Missed Dose 10. Related Products & Titration Care 11. Storage & System Maintenance Tips 12. Clinical Fact Box 13. Managing New Patient Concerns 14. User Feedback & Insights 15. Frequently Asked Questions (FAQs) 16. Regulatory Disclaimer & References
These include: Semaglutide (Wegovy) recommended by NICE for weight management in eligible adults (NICE TA875) Liraglutide (Saxenda) recommended by NICE for weight management in selected groups (NICE TA664) Orlistat available for weight management under NICE guidance (NICE CG189) Naltrexone/bupropion (Mysimba) does not currently have a positive NICE recommendation for weight management in England and should not be assumed to be a routinely recommended option